WO2003000185A3 - Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 - Google Patents
Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 Download PDFInfo
- Publication number
- WO2003000185A3 WO2003000185A3 PCT/US2002/019617 US0219617W WO03000185A3 WO 2003000185 A3 WO2003000185 A3 WO 2003000185A3 US 0219617 W US0219617 W US 0219617W WO 03000185 A3 WO03000185 A3 WO 03000185A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cyclooxygenase
- component
- complex mixtures
- selective inhibition
- exhibiting selective
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02737562A EP1423132A4 (en) | 2001-06-20 | 2002-06-20 | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
NZ530213A NZ530213A (en) | 2001-06-20 | 2002-06-20 | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
CA002450478A CA2450478A1 (en) | 2001-06-20 | 2002-06-20 | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
US10/480,145 US7195785B2 (en) | 2001-06-20 | 2002-06-20 | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
JP2003506631A JP2004534806A (en) | 2001-06-20 | 2002-06-20 | Complex mixtures showing selective inhibition of cyclooxygenase 2 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/885,721 | 2001-06-20 | ||
US09/885,721 US7205151B2 (en) | 2001-06-20 | 2001-06-20 | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003000185A2 WO2003000185A2 (en) | 2003-01-03 |
WO2003000185A3 true WO2003000185A3 (en) | 2004-03-11 |
Family
ID=25387562
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/019617 WO2003000185A2 (en) | 2001-06-20 | 2002-06-20 | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
Country Status (6)
Country | Link |
---|---|
US (4) | US7205151B2 (en) |
EP (2) | EP2277526A1 (en) |
JP (2) | JP2004534806A (en) |
CA (1) | CA2450478A1 (en) |
NZ (1) | NZ530213A (en) |
WO (1) | WO2003000185A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8846115B2 (en) | 2001-11-13 | 2014-09-30 | Metaproteomics, Inc. | Anti-inflammatory cyclooxygenase inhibitors |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040033938A1 (en) * | 2000-09-12 | 2004-02-19 | Britten Nancy J. | Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis |
US7901713B2 (en) * | 2001-06-20 | 2011-03-08 | Metaproteomics, Llc | Inhibition of COX-2 and/or 5-LOX activity by fractions isolated or derived from hops |
US8168234B2 (en) * | 2001-06-20 | 2012-05-01 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US8142819B2 (en) * | 2002-10-21 | 2012-03-27 | Metaproteomics, Llc | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
US20040115290A1 (en) * | 2001-06-20 | 2004-06-17 | Tripp Matthew L. | Modulation of inflammation by hops fractions and derivatives |
US7901714B2 (en) * | 2001-06-20 | 2011-03-08 | Metaproteomics, Llp | Treatment modalities for autoimmune diseases |
US7815944B2 (en) * | 2001-06-20 | 2010-10-19 | Metaproteomics, Llc | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment of prevention of gastric toxicity |
US7718198B2 (en) * | 2001-06-20 | 2010-05-18 | Metaproteomics, Llc | Treatment modalities for autoimmune diseases |
US7270835B2 (en) * | 2001-06-20 | 2007-09-18 | Metaproteomics, Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response |
US8206753B2 (en) * | 2001-06-20 | 2012-06-26 | Metaproteomics, Llc | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
US7205151B2 (en) * | 2001-06-20 | 2007-04-17 | Metaproteomics, Llc | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
MXPA05004288A (en) * | 2002-10-21 | 2005-08-02 | Metaproteomics Llc | Compositions that treat or inhibit pathological conditions associated with inflammatory response. |
DE10256031A1 (en) * | 2002-11-30 | 2004-06-09 | Nateco 2 Gmbh & Co. Kg | Process for the preparation of a xanthohumol-enriched hop extract and its use |
US20080153894A1 (en) * | 2002-12-19 | 2008-06-26 | Pharmacia Corporation | Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis |
US7144590B2 (en) * | 2003-01-09 | 2006-12-05 | Lipoprotein Technologies, Inc. | Bioactive compositions derived from humulus lupulus |
WO2004089357A2 (en) * | 2003-04-02 | 2004-10-21 | Regents Of The University Of Minnesota | Anti-fungal formulation of triterpene and essential oil |
EP1626731B1 (en) * | 2003-05-22 | 2009-01-21 | Metaproteomics, LLC | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
US7641923B1 (en) * | 2004-02-02 | 2010-01-05 | S. S. Steiner, Inc. | Process and product for inhibiting or preventing bacterial infections |
US8367086B1 (en) * | 2004-02-02 | 2013-02-05 | S.S. Steiner, Inc. | Process and product for inhibiting or preventing bacterial infections |
CA2556392C (en) | 2004-02-23 | 2013-06-04 | Segal, Janet | Feeds containing hop acids and uses thereof as supplements in animal feeds |
US7914831B2 (en) * | 2004-02-27 | 2011-03-29 | Metaproteomics, Llc | Synergistic anti-inflammatory pharmaceutical compositions and related methods using curcuminoids or methylxanthines |
US20050192356A1 (en) | 2004-02-27 | 2005-09-01 | Babish John G. | Synergistic anti-inflammatory pharmaceutical compositions and methods of use |
SE0400996D0 (en) * | 2004-04-16 | 2004-04-16 | Alltech Ireland Inc | Use of plants, plant extracts and nature-identical components from plants to affect rumen fermentation and to improve the energy and protein retention of ruminants |
BRPI0419105A (en) * | 2004-10-01 | 2007-12-11 | Ache Lab Farmaceuticos Sa | uses of karyophyllenes or compositions comprising karyophyllenes, method of treating inflammatory conditions and inflammatory pains, inhibition method and composition comprising karyophyllene |
AU2005304317A1 (en) * | 2004-11-13 | 2006-05-18 | Metaproteomics, Llc | Compositions exhibiting inhibition of cyclooxygenase-2 |
US7745209B2 (en) | 2005-07-26 | 2010-06-29 | Corning Incorporated | Multilayered cell culture apparatus |
US20080248131A1 (en) * | 2005-08-09 | 2008-10-09 | Metaproteomics, Llc | Protein Kinase Modulation by Hops and Acacia Products |
EP1968559A4 (en) * | 2005-12-09 | 2013-08-07 | Metaproteomics Llc | Anti-inflammatory botanical products for the treatment of metabolic syndrome and diabetes |
JP2009518439A (en) * | 2005-12-09 | 2009-05-07 | メタプロテオミクス,エルエルシー | Protein kinase regulation by hops and acacia products |
US7405195B2 (en) * | 2006-03-27 | 2008-07-29 | Natural Beauty Bio-Technology Limited | Cosmetic compositions |
JP2009541326A (en) * | 2006-06-20 | 2009-11-26 | メタプロテオミクス, エルエルシー | Beta acid-based protein kinase-regulated cancer therapy |
US20080051466A1 (en) * | 2006-06-20 | 2008-02-28 | Metaproteomics, Llc | Isoalpha acid based protein kinase modulation cancer treatment |
FR2910325B1 (en) * | 2006-12-22 | 2010-03-19 | Kronenbourg Brasseries | USE OF LUPULONES FOR THE PREVENTION AND THERAPY OF COLORECTAL CANCER. |
MX2009010049A (en) * | 2007-03-19 | 2010-03-04 | Metaproteomics Llc | Methods and compositions for promoting bone and joint health. |
JP2010526882A (en) * | 2007-05-11 | 2010-08-05 | メタプロテオミクス, エルエルシー | Methods and compositions for detoxifying heavy metals |
CA2708613A1 (en) * | 2007-12-10 | 2009-06-18 | Metaproteomics, Llc | Substituted 1,3-cyclopentadione multi-target protein kinase modulators of cancer, angiogenesis and the inflammatory pathways associated therewith |
JP2011516492A (en) * | 2008-04-02 | 2011-05-26 | メタプロテオミクス, エルエルシー | Attenuation of endothelial inflammation and endothelium-monocyte interaction by substituted 1,3-cyclopentadione |
EP2274411A4 (en) * | 2008-04-11 | 2016-01-20 | Betal Llc | Xanthohumol compositions and methods for treating skin diseases or disorders |
CA2792837A1 (en) * | 2010-03-17 | 2011-09-22 | Arbonne International Llc | Oral supplement |
CA2853974C (en) | 2010-10-30 | 2020-11-10 | Kindex Therapeutics, Llc | Cis 3,4-dihydroxy-2-(3-methylbutanoyl)-5-(3-methylbutyl)-4-(4-methylpentanoyl)cyclopent-2-en-1-one derivatives, substantially enantiomerically pure compositions and methods |
JP2013155130A (en) * | 2012-01-30 | 2013-08-15 | Lion Corp | Nitric oxide production suppressibility improver and application thereof |
US20140255587A1 (en) * | 2013-03-11 | 2014-09-11 | S.S. Steiner, Inc. | Novel hop powders |
KR102474030B1 (en) | 2016-08-23 | 2022-12-06 | 삼성전자주식회사 | Flexible Display Apparatus and Manufacturing Method of Flexible Display Apparatus |
US11666553B2 (en) | 2020-02-25 | 2023-06-06 | North Cell Pharmceticals Inc. | Method of reducing anxiety in non-human mammals by increasing brain serotonin levels |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3932603A (en) * | 1971-05-28 | 1976-01-13 | General Foods Corporation | Oral preparations for reducing the incidence of dental caries |
Family Cites Families (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3933919A (en) | 1964-12-15 | 1976-01-20 | Geoffrey Wilkinson | Hydroformylation of mono-α-olefins and mono-α-acetylenes |
US3451821A (en) * | 1965-03-01 | 1969-06-24 | Kalamazoo Spice Extract Co | Increasing the utilization of hops and improving flavor control of malt beverages and the like |
GB1140545A (en) | 1965-03-01 | 1969-01-22 | Kalamazoo Spice Extract Co | Hop flavours for malt beverages and the like |
US3720517A (en) * | 1970-12-21 | 1973-03-13 | Hamm T Brewing Co | Preparation of a fermented malt champagne |
GB1372932A (en) | 1971-03-15 | 1974-11-06 | Gen Foods Corp | Anti-caries compositions |
US3965188A (en) * | 1972-01-10 | 1976-06-22 | Miller Brewing Company | Hop extract process and product |
CH617326A5 (en) * | 1975-12-04 | 1980-05-30 | Siegfried Ag | |
US4170638A (en) * | 1976-11-05 | 1979-10-09 | S. S. Steiner, Inc. | Method for producing a deodorant |
US4148873A (en) * | 1976-11-05 | 1979-04-10 | S. S. Steiner, Inc. | Method for treating the skin with extracts of hops |
US4123561A (en) * | 1977-02-01 | 1978-10-31 | S.S. Steiner, Inc. | Method for processing hops for brewing |
US4401684A (en) * | 1981-10-01 | 1983-08-30 | Australian Hop Marketers Pty. Ltd. | Preservation of hops utilizing ascorbic acid |
BE896610A (en) * | 1982-05-06 | 1983-08-16 | Hop Developments Ltd | EXTRACTION OF PLANT MATERIAL USING CARBONIC ANHYDRIDE |
US4473551A (en) * | 1982-08-23 | 1984-09-25 | Faxon Pharmaceuticals, Inc. | Anti-inflammatory composition |
US4590296A (en) * | 1984-01-25 | 1986-05-20 | Miller Brewing Company | Process for separation of beta-acids from extract containing alpha-acids and beta-acids |
US4644084A (en) | 1984-01-25 | 1987-02-17 | Miller Brewing Company | Preparation of tetrahydroisohumulones |
GB2187755B (en) * | 1984-02-28 | 1990-03-28 | Kalamazoo Holdings Inc | Separation of the constituents of co2 hop extracts |
SU1247011A1 (en) | 1985-02-20 | 1986-07-30 | Специальное Конструкторское Бюро Химизации Научно-Производственного Объединения "Аэрозоль" | Agent for hair care |
US4767640A (en) * | 1985-10-29 | 1988-08-30 | Miller Brewing Company | Light stable hop extracts and method of preparation |
US4692280A (en) * | 1986-12-01 | 1987-09-08 | The United States Of America As Represented By The Secretary Of Commerce | Purification of fish oils |
JP2594787B2 (en) | 1987-02-27 | 1997-03-26 | 大洋香料株式会社 | Caries prevention agent |
US5041300A (en) * | 1987-04-03 | 1991-08-20 | Kalamazoo Holdings, Inc. | Hop flavor which is odor forming impurity free |
DE3712986A1 (en) * | 1987-04-16 | 1988-10-27 | Marbert Gmbh | MEDICAL PREPARATIONS BASED ON TREASURE EXTRACT, METHOD FOR THE PRODUCTION THEREOF AND USE OF TREATMENT EXTRACT FOR THE PRODUCTION OF COSMETIC PREPARATIONS AND A SPECIAL TREATMENT EXTRACT |
US4857554A (en) * | 1987-08-17 | 1989-08-15 | Georgios Kallimanis | Method for the treatment of psoriasis |
US5082975A (en) | 1988-08-15 | 1992-01-21 | Kalamazoo Holdings, Inc. | Synthesis of hexahydrolupulone, novel forms thereof, and its use as a selective inhibitor of cell growth and multiplication |
US5166449A (en) | 1988-08-15 | 1992-11-24 | Kalamazoo Holdings, Inc. | Synthesis of hexahydrolupulone, novel forms thereof, and its use as a selective inhibitor of cell growth and multiplication |
DE3931147A1 (en) | 1989-09-19 | 1991-03-28 | Solong Natural Ltd | New nerve tonic contg. extract of avena sativa - used to treat frigidity and increase libido in women |
US5013571A (en) | 1990-01-31 | 1991-05-07 | Pfizer Inc. | Methods for making tetrahydroisoalpha and hexahydroisoalpha acids |
EP0474892B1 (en) * | 1990-09-10 | 1996-04-10 | Fromm, Mayer-Bass Limited | Process for the isomerisation of humulone in a carbon dioxide-hop extract and method for extracting the isohumulone |
JP3155003B2 (en) * | 1990-11-06 | 2001-04-09 | サントリー株式会社 | Method for producing hop extract and hop extract obtained by the method |
JP2514860B2 (en) * | 1990-11-30 | 1996-07-10 | アサヒビール株式会社 | Hop extract used for elimination of active oxygen and its utilization |
TW199905B (en) * | 1992-02-03 | 1993-02-11 | J E Siebel Sons Company Inc | Method and composition for enhancing foam properties of fermented malt beverages |
RU2045955C1 (en) * | 1992-02-24 | 1995-10-20 | Никитина Татьяна Ивановна | Method for treating adnexites |
WO1994003192A1 (en) * | 1992-07-29 | 1994-02-17 | Drymed A/S | Composition comprising fertilized shell eggs |
US5286506A (en) * | 1992-10-29 | 1994-02-15 | Bio-Technical Resources | Inhibition of food pathogens by hop acids |
US5370863A (en) * | 1992-12-16 | 1994-12-06 | Miller Brewing Company | Oral care compositions containing hop acids and method |
US5296637A (en) | 1992-12-31 | 1994-03-22 | Kalamazoo Holdings, Inc. | Production of odor-free tetrahydroisohumulates from alpha acids via their tetrahydrohumulates and subsequent isomerization |
JP3513877B2 (en) * | 1993-02-12 | 2004-03-31 | サントリー株式会社 | Hop extract, method for producing the same, and method for producing highly aromatic beer |
JPH06312924A (en) * | 1993-04-28 | 1994-11-08 | Asahi Breweries Ltd | Utilization of humulones having antioxidant action |
JP3431250B2 (en) * | 1993-12-28 | 2003-07-28 | 日本臓器製薬株式会社 | Beverage and method for producing the same |
JP2677762B2 (en) * | 1994-04-08 | 1997-11-17 | 株式会社神戸製鋼所 | Oil-cooled compressor |
EP0677289B1 (en) | 1994-04-12 | 1999-01-13 | Hoechst Marion Roussel, Ltd. | Pharmaceutical composition for treating osteoporosis |
JPH0873369A (en) | 1994-09-01 | 1996-03-19 | Fuairudo:Kk | Tea for health |
JPH0967245A (en) * | 1995-08-28 | 1997-03-11 | Asahi Breweries Ltd | Bathing agent |
US5827895A (en) * | 1996-02-27 | 1998-10-27 | Regents Of The University Of Minnesota | Hexahydrolupulones useful as anticancer agents |
JP3254553B2 (en) * | 1996-03-06 | 2002-02-12 | アサヒビール株式会社 | Anti-caries material, its production method and use |
US6020019A (en) * | 1996-03-26 | 2000-02-01 | Miller Brewing Company | Hydrogenation of hop soft resins using CO2 |
JPH1025247A (en) * | 1996-07-10 | 1998-01-27 | Asahi Breweries Ltd | Preventive and therapeutic agent for gastritis and gastric and duodenal ulcer |
US6589994B1 (en) * | 1996-08-30 | 2003-07-08 | Nps Pharmaceuticals, Inc. | Treating a variety of pathological conditions, including spasticity and convulsions, by effecting a modulation of CNS activity with isovaleramide, isovaleric acid, or a related compound |
JP4083831B2 (en) | 1996-11-20 | 2008-04-30 | 株式会社カネボウ化粧品 | Skin preparation |
US5968539A (en) * | 1997-06-04 | 1999-10-19 | Procter & Gamble Company | Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria |
US6251461B1 (en) * | 1997-10-10 | 2001-06-26 | S. S. Steiner, Inc. | Antimicrobial activity of hops extract against Clostridium botulinum, Clostridium difficile and Helicobacter pylori |
CA2321737A1 (en) | 1998-03-04 | 1999-09-10 | Nps Pharmaceuticals, Inc. | Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a nsaid |
DE19841615A1 (en) * | 1998-09-11 | 2000-03-16 | Fritz Armin Mueller | Medicinal wine for alleviating pain and other symptoms of premenstrual syndrome, comprising mixture of extracts of different plants in dry white wine |
ES2147538B1 (en) * | 1999-01-29 | 2001-04-01 | Revlon Consumer Prod Corp | A CAPILLARY LOTION WITH IMPROVED PROPERTIES IN ITS HAIR PROTECTIVE AND PREVENTIVE ACTION OF HIS FALL, AND REDUCTION OF THE EXTERNAL EFFECTS OF ANDROGENETIC ALOPECIA AND WITH THAT OF THE HAIR FALL. |
US6801860B1 (en) * | 1999-02-15 | 2004-10-05 | Genetics Institute, Llc | Crystal structure of cPLA2 and methods of identifying agonists and antagonists using same |
US6383527B1 (en) | 1999-03-04 | 2002-05-07 | Nps Pharmaceuticals, Inc. | Compositions comprising valerian extracts, isovaleric acid or derivatives thereof with a NSAID |
US20010031305A1 (en) | 1999-05-07 | 2001-10-18 | Michael Smith | Hop extract of defined composition |
GB2367492A (en) | 1999-06-02 | 2002-04-10 | Oxford Natural Products Plc | Combination of glucosamine with herbal extracts of triptergium, ligustrum and erycibe |
US6129907A (en) * | 1999-08-04 | 2000-10-10 | Colgate Palmolive Company | Stable hydrogenated lupulone antibacterial oral compositions |
US6200594B1 (en) * | 1999-12-29 | 2001-03-13 | Vital Dynamics, Inc. | Breast-enhancing, herbal compositions and methods of using same |
US6953593B2 (en) * | 2000-02-01 | 2005-10-11 | Lipoprotein Technologies, Inc. | Sustained-release microencapsulated delivery system |
US6583322B1 (en) * | 2000-02-25 | 2003-06-24 | Kalamazoo Holdings, Inc. | Dihydro and hexahydro isoalpha acids having a high ratio of trans to cis isomers, production thereof, and products containing the same |
US20020086070A1 (en) * | 2000-03-11 | 2002-07-04 | Kuhrts Eric Hauser | Anti-inflammatory and connective tissue repair formulations |
KR20030005252A (en) * | 2000-03-31 | 2003-01-17 | 니신 오일 밀스 가부시키가이샤 | External preparation for the skin and beautifying agents |
US6440465B1 (en) * | 2000-05-01 | 2002-08-27 | Bioderm, Inc. | Topical composition for the treatment of psoriasis and related skin disorders |
DE10031955A1 (en) | 2000-06-30 | 2002-01-17 | Deutsches Krebsforsch | Curcumin derivatives with improved water solubility compared to curcumin and medicaments containing them |
US6908630B2 (en) * | 2000-08-01 | 2005-06-21 | Metaproteomics, Llc | Combinations of sesquiterpene lactones and ditepene triepoxide lactones for synergistic inhibition of cyclooxygenase-2 |
US20020076452A1 (en) * | 2000-08-01 | 2002-06-20 | Ashni Naturaceuticals, Inc. | Combinations of sesquiterpene lactones and ditepene lactones or triterpenes for synergistic inhibition of cyclooxygenase-2 |
FR2815227B1 (en) * | 2000-10-17 | 2003-04-11 | Schwartz Laboratoires Robert | ANTI-STRESS COMPOSITION FOR PRIMARY INCORPORATION IN NUTRITIONAL VEHICLES |
US6391346B1 (en) * | 2001-04-05 | 2002-05-21 | Thomas Newmark | Anti-inflammatory, sleep-promoting herbal composition and method of use |
US20040219240A1 (en) * | 2001-06-20 | 2004-11-04 | Babish John G. | Anti-inflammatory pharmaceutical compositions for reducing inflammation and the treatment or prevention of gastric toxicity |
US8142819B2 (en) * | 2002-10-21 | 2012-03-27 | Metaproteomics, Llc | Synergistic compositions that treat or inhibit pathological conditions associated with inflammatory response |
US20040115290A1 (en) * | 2001-06-20 | 2004-06-17 | Tripp Matthew L. | Modulation of inflammation by hops fractions and derivatives |
US7205151B2 (en) * | 2001-06-20 | 2007-04-17 | Metaproteomics, Llc | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
EP1446136B1 (en) * | 2001-10-26 | 2010-09-29 | Metaproteomics, LLC | Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
US7144590B2 (en) * | 2003-01-09 | 2006-12-05 | Lipoprotein Technologies, Inc. | Bioactive compositions derived from humulus lupulus |
-
2001
- 2001-06-20 US US09/885,721 patent/US7205151B2/en not_active Expired - Lifetime
-
2002
- 2002-06-20 JP JP2003506631A patent/JP2004534806A/en active Pending
- 2002-06-20 EP EP10013109A patent/EP2277526A1/en not_active Withdrawn
- 2002-06-20 US US10/480,145 patent/US7195785B2/en not_active Expired - Lifetime
- 2002-06-20 WO PCT/US2002/019617 patent/WO2003000185A2/en active Application Filing
- 2002-06-20 EP EP02737562A patent/EP1423132A4/en not_active Withdrawn
- 2002-06-20 CA CA002450478A patent/CA2450478A1/en not_active Abandoned
- 2002-06-20 NZ NZ530213A patent/NZ530213A/en not_active IP Right Cessation
- 2002-10-24 US US10/280,198 patent/US7332185B2/en not_active Expired - Lifetime
-
2007
- 2007-01-16 US US11/623,400 patent/US20070172532A1/en not_active Abandoned
-
2009
- 2009-06-17 JP JP2009144756A patent/JP2009203244A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3932603A (en) * | 1971-05-28 | 1976-01-13 | General Foods Corporation | Oral preparations for reducing the incidence of dental caries |
Non-Patent Citations (1)
Title |
---|
See also references of EP1423132A4 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8846115B2 (en) | 2001-11-13 | 2014-09-30 | Metaproteomics, Inc. | Anti-inflammatory cyclooxygenase inhibitors |
Also Published As
Publication number | Publication date |
---|---|
US20070172532A1 (en) | 2007-07-26 |
EP1423132A2 (en) | 2004-06-02 |
EP1423132A4 (en) | 2005-02-09 |
CA2450478A1 (en) | 2003-01-03 |
US20030008021A1 (en) | 2003-01-09 |
JP2009203244A (en) | 2009-09-10 |
US20030113393A1 (en) | 2003-06-19 |
JP2004534806A (en) | 2004-11-18 |
EP2277526A1 (en) | 2011-01-26 |
WO2003000185A2 (en) | 2003-01-03 |
US7195785B2 (en) | 2007-03-27 |
US20050042317A1 (en) | 2005-02-24 |
US7332185B2 (en) | 2008-02-19 |
NZ530213A (en) | 2006-01-27 |
US7205151B2 (en) | 2007-04-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003000185A3 (en) | Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 | |
EP1184031A3 (en) | Foaming cosmetic cream for the treatment of fatty skins | |
NZ502584A (en) | oil blend for use in a chocolate alternative containing palm kernel stearin, hydrogenated palm kernel stearin and hardened palm or cottonseed oil | |
WO2004060101A3 (en) | Compositions containing oil silicon-polyamide polymer and short chain ester | |
WO2008097553A3 (en) | Citrus oil compositions and methods of use | |
EP0826366A3 (en) | Cosmetic compositions containing hydroxy acid or retinoid | |
CA2381678A1 (en) | Friction control composition with enhanced retentivity | |
WO2002090493A3 (en) | Δ4-desaturase genes and uses thereof | |
WO2002085109A3 (en) | Bactericidal composition comprising polylysin and plant natural oils | |
NL300225I1 (en) | New topical compositions with a high glycol content in the form of a liquid H / E emulsion. | |
EP0858799A3 (en) | Compositions containing hydroxyacids or retinoids | |
IL189129A0 (en) | Aerated compositions comprising hydrophobin | |
TR199800232T1 (en) | Active compound combinations of pythroids and insect growth inhibitors. | |
WO2007002837A3 (en) | Methods and compositions for the prevention and treatement of inflammatory disease | |
CA2332174A1 (en) | Nutritional supplement based on blackcurrant seed oil | |
WO2004091645A3 (en) | Composition comprising rosmarinic acid, borneol and ginsenoside | |
WO1999003446A3 (en) | Antimicrobial cosmetic compositions | |
EP1108365A3 (en) | Encapsulated long chain alcohols | |
WO2001094951A3 (en) | Inhibitors of c-reactive protein induced inflammation | |
DE69701082T2 (en) | STABLE HERBICIDAL COMPOSITIONS CONTAINING METAL CHELATES OF HERBICIDAL DIONES | |
MX9306922A (en) | FACTOR THAT ENHANCES THE ACTIVITY OF A PESTICIDE RELATED TO UNBACILO, METHOD FOR ITS ONTENTION AND PESTICIDE COMPOSITION WHICH IT INCLUDES. | |
DE60123413D1 (en) | COSMETIC PREPARATIONS CONTAINING KAUKAUBUTTER | |
BR9913554A (en) | Composition of plastic fat with reduced calorie | |
MY121109A (en) | Composition. | |
EA200300630A1 (en) | LIQUID COMPOSITION FOR HOT |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2450478 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002310484 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 530213 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003506631 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002737562 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2002737562 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10480145 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 530213 Country of ref document: NZ |